REDUCTION IN LEVODOPA BIOAVAILABILITY ASSOCIATED WITH FERROUS SULFATE ADMINISTRATION

被引：0
|
作者：
CAMPBELL, N [1 ]
机构：
[1] MEM UNIV NEWFOUNDLAND,DIV CLIN PHARMACOL,ST JOHNS A1C 5S7,NEWFOUNDLAND,CANADA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1988年 / 43卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：167 / 167
页数：1
相关论文
共 50 条
  • [31] A comparison of the bioavailability of ferrous fumarate and ferrous sulfate in non-anemic Mexican women and children consuming a sweetened maize and milk drink
    Harrington, M.
    Hotz, C.
    Zeder, C.
    Polvo, G. O.
    Villalpando, S.
    Zimmermann, M. B.
    Walczyk, T.
    Rivera, J. A.
    Hurrell, R. F.
    EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2011, 65 (01) : 20 - 25
  • [32] FERROUS SULFATE DOSIMETRY
    LEVESQUE, R
    PHYSICS IN MEDICINE AND BIOLOGY, 1972, 17 (06): : 889 - &
  • [33] Ferrous sulfate toxicity
    Pestaner, JP
    Mullick, F
    Centeno, J
    LABORATORY INVESTIGATION, 1996, 74 (01) : 885 - 885
  • [34] Ferrous sulfate for CuHXs
    不详
    MATERIALS PERFORMANCE, 1999, 38 (11) : 59 - 59
  • [35] FERROUS SULFATE POISONING
    GALLA, SJ
    NEW ENGLAND JOURNAL OF MEDICINE, 1960, 263 (20): : 1035 - 1035
  • [36] FERROUS SULFATE POISONING
    不详
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1953, 151 (04): : 301 - 301
  • [37] Ferrous sulfate for worms
    Putnam, M
    JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1937, 108 : 649 - 649
  • [38] FERROUS SULFATE POISONING
    CLARK, WM
    JUROW, SS
    WALFORD, RL
    WARTHEN, RO
    AMA AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1954, 88 (02): : 220 - 226
  • [39] The hydrosoluble fiber Plantago ovata husk improves levodopa (with carbidopa) bioavailability after repeated administration
    Diez, M. Jose
    Garcia, Juan J.
    Prieto, Carlos
    Fernandez, Nelida
    Sahagun, Ana
    Sierra, Matilde
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2008, 271 (1-2) : 15 - 20
  • [40] Age associated effects of levodopa administration on striatal acetylcholinesterase activity
    Messripour, M.
    Mesripour, A.
    MOVEMENT DISORDERS, 2016, 31 : S291 - S291
12345